INVO Fertility, Inc. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
INVO Fertility, Inc. (IVF) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $141.33 thousand as of 2024-09-30, per its 10-K filed 2025-04-30.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2025-04-30
- 2024-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $141.33K; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed $227.95K.
- 2023-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $264.93K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed |
|---|---|---|
| 2024-09-30 | $141.33K 10-K · filed 2025-04-30 | $227.95K 10-Q · filed 2024-11-19 |
| 2023-12-31 | $264.93K 10-K · filed 2025-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |